-
-
-
-
-
-
-
CRISPR Therapeutics (CRSP) PT Raised to $170 at Needham & Company
-
-
-
-
-
-
-
Verso Corporation (VRS), Atlas And Blue Wolf Announce Agreement To End Proxy Contest
-
-
-
-
-
-
-
Zealand Pharma A/S (ZEAL) PT Raised to $32 at Needham & Company
-
-
-
-
-
-
-
Biohaven Pharmaceutical Holding (BHVN) PT Raised to $70 at Needham & Company
-
-
-
-
-
-
-
Needham & Company Starts Moderna (MRNA) at Buy
-
-
-
-
-
-
Nabriva Therapeutics AG (NBRV) PT Lowered to $15 at Needham & Company
-
-
-
-
-
-
-
Neurocrine Bio. (NBIX) PT Raised to $125 at Needham & Company
-
198 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All